JYNT · JOINT Corp
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA from continuing operations non-GAAP | $3,678,687 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA from discontinued operations non-GAAP | $2,962,738 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Clinics refranchised | 29 | Q2 2026 | — |
| Comp sales | -2.8% | Q2 2026 | — |
| Company-owned or managed clinics | 45 | Q2 2026 | — |
| Consolidated Adjusted EBITDA non-GAAP | $6,641,425 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Franchised clinics | 896 | Q2 2026 | — |
| Free cash flow non-GAAP | $225,192 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Total clinic count | 941 | Q2 2026 | — |
|
|
|||
| Share repurchase plan remaining | $4.5M | Q1 FY2026 | — |
| Stock repurchases | 137,000 | Q1 FY2026 | — |
| System-wide sales | $126.1M | first quarter of 2026 | — |
|
|
|||
| Clinics closed | 36 | Full year 2025 | — |
| Clinics opened | 29 | Full year 2025 | — |
| Franchise licenses sold | 31 | Full year 2025 | — |
| Patient visits | 14.4M | Full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
JYNT
this stock
JOINT Corp
|
$118.38M | -3.2% | +16.2% | 31.0 | 3.3% |
|
HCA
HCA Healthcare, Inc.
|
$95.24B | -8.1% | +7.1% | 14.8 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.64B | -4.8% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.61B | +41.3% | +0.9% | 10.8 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.49B | -1.6% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| JYNT | -0.1% | +1.1% | -1.4% | +1.8% | -3.2% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +1.3% | -2.6% | -13.0% | -0.7% | -15.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.